Antimicrobial Resistance Awareness and Antibiotic Prescribing Behavior Among Healthcare Workers
DOI:
https://doi.org/10.5195/ijms.2025.4043Keywords:
Multi-Drug Resistance, Microorganisms, Antibiotic Prescribing, Health Care Personnel , Knowledge, Attitudes, Practic, Infection ControlAbstract
Background: Antimicrobial resistance (AMR) is on the rise worldwide and presents a significant threat in Iraq, where ongoing conflict and fragile health systems contribute to elevated levels of multi-drug-resistant (MDR) organisms. It is increasingly recognized as a public health challenge in Iraq, largely due to the prevalent misuse and over-prescription of antibiotics. Research indicates that numerous physicians in public hospitals often prescribe antibiotics based on empirical evidence while community pharmacists commonly dispense antibiotics without prescriptions, which exacerbates self-medication and misuse. Although national AMR control plans are in place, their implementation is still limited. Surveillance initiatives have uncovered high levels of multidrug-resistant bacteria, including Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus, in both adult and pediatric populations. It is essential to raise awareness about AMR in Iraq. This necessitates coordinated efforts across healthcare, agriculture, and environmental sectors consistent with the One Health approach to encourage responsible antibiotic usage, enhance surveillance, and enforce regulatory measures.
Objective: The current study conducted to evaluate healthcare workers’ (HCWs) awareness, practices, and institutional barriers to AMR control in a sample of Baghdad hospitals.
Methods: A cross-sectional survey from July to September 2025 was designed. About 196 HCWs across five hospitals in Baghdad City were involved to assess perceptions of AMR, infection control practices, and stewardship awareness.
Results: The largest proportion of participants were from Baghdad Medical City (64.3%), followed by Al-Yarmouk Teaching Hospital (16.8%), Al-Kindy Teaching Hospital (10.7%), Madain Hospital (7.7%), and Zafaraniyah General Hospital (0.5%). Most respondents were residents (39.8%) or pharmacists (35.7%); 86.2% considered AMR a major problem. Gram-negative (43.2%) and Gram-positive (42.1%) were almost equal. The most frequently reported Gram-positive bacteria were Staphylococcus aureus (12.6%) and Methicillin-resistant Staphylococcus aureus (MRSA) (6.6%). Other reported organisms included Vancomycin-resistant Enterococcus (2.2%) and Streptococcus (1.1%). For Gram-negative organisms, the most problematic species were Pseudomonas aeruginosa (14.2%), Acinetobacter baumannii (6.0%), Klebsiella pneumoniae (5.5%), and Escherichia coli (2.2%). Just over half (53.1%) of HCWs reported that their hospitals had infection control policies, while (36.2%) stated no such policies existed, and (10.7%) were unaware. Training on infection prevention and control was infrequent: the majority (62.8%) reported no training at all, while only (21.4%) received training every 6 months, (8.7%) every 3 months, and (7.1%) monthly. Awareness of stewardship programs was limited (45.4%). The internal medicine ward (12.8%), surgery wards (9.7%), and intensive care unit (9.4%) were significantly associated with MDR infections. The resuscitation care unit (7.7%), burn wards (2.0%), and respiratory wards (2.0%) were also reported, while other wards such as pediatrics, hematology, and infection control unit had fewer mentions.
Conclusion: Despite widespread recognition of AMR, Iraqi hospitals face critical gaps in training, stewardship, and policy implementation. Nearly two-thirds of HCWs had never received infection prevention training. Pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus were equally detected and were the most common. Multi drug-resistant infections were concentrated in internal medicine, surgery, and intensive care units, with Gram-negative organisms predominating. Urgent, system-wide interventions are needed to strengthen infection control and curb the growing burden of multi drug resistance.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Abdalrhman Salah

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org


